The potential relevant mechanisms for obesity-associated hypertension may be related to renin–angiotensin–aldosterone system/sympathetic nervous system upregulation, adipokine hyperactivation, insulin tolerance, and immune disturbances, as well as structural and functional kidney, heart, and adipocyte alterations [61,62]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.